Frontlight ResearchEarly access
CompletedPhase 4
Comparative Effectiveness of Cystine Versus Nicotine Replacement Therapy
Key facts
- Who runs it
- Loma Linda University
- Where
- Mongolia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 1,307 people enrolled
- Started
- 27 Jan 2022
- Ended
- 20 Apr 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Cytisine
- Nicotine Replacement Therapy (NRT)
- Record updated
- 19 September 2024
Who can take part
- Age
- 18 years to 100 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (11)Hide the full registry criteria
Who can take part
- Seeking smoking cessation treatment
- Ages 18 years or older
- Currently smoking > 5 cigarettes per day
- Willingness to make quit attempt with pharmacotherapy
- Able to provide verbal and written informed consent
- Have telephone access
Who cannot take part
- Clinical disorder that contraindicates use of NRT or Cytisine (heart attack, stroke, severe angina within the past 2 weeks, uncontrolled hypertension, phaeochromocytoma, severe mental illness)
- Pregnancy or currently breastfeeding
- Current users of NRT (patch, gum, lozenge)
- Current users of non_NRT smoking cessation pharmacotherapy
- Enrolled in another smoking cessation program (non-governmental)
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
A pragmatic, single blinded, randomized, controlled non-inferiority trial of Cytisine versus Nicotine Replacement Therapy for continuous abstinence is conducted in the government run primary health hospitals in Mongolia.
The 2 groups in the trial
- Usual Care GroupExisting treatment, for comparison
Subjects are asked to completely stop smoking on their quit day and use a daily Nicotine Replacement Therapy (NRT) patch for 25 days.
Treatment: Nicotine Replacement Therapy (NRT)
- Treatment GroupTreatment being tested
Subjects will start a 25-day course of Cytisine tablets started during the four days before the quit date and are asked to reduce smoking during this time.
Treatment: Cytisine
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparative Effectiveness of Cystine Versus Nicotine Replacement Therapy (NRT) in the National Smoking Cessation Program of Mongolia: A Pragmatic Non-Inferiority Trial
- Record updated
- 19 September 2024